Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 2
2010 6
2011 5
2012 4
2013 3
2014 3
2015 13
2016 7
2017 5
2018 4
2019 6
2020 9
2021 6
2022 11
2023 12
2024 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Peyrin-Biroulet L, Rahier JF, Kirchgesner J, Abitbol V, Shaji S, Armuzzi A, Karmiris K, Gisbert JP, Bossuyt P, Helwig U, Burisch J, Yanai H, Doherty GA, Magro F, Molnar T, Löwenberg M, Halfvarson J, Zagorowicz E, Rousseau H, Baumann C, Baert F, Beaugerie L; I-CARE Collaborator Group. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2023 Mar;21(3):771-788.e10. doi: 10.1016/j.cgh.2022.09.018. Epub 2022 Sep 22. Clin Gastroenterol Hepatol. 2023. PMID: 36152897 Free article.
Sinonasal effects of external dacryocystorhinostomy.
Eyigor H, Cetinkaya EA, Coban DT, Ozturk G, Erdem Ö. Eyigor H, et al. Among authors: coban dt. J Laryngol Otol. 2021 Sep;135(9):791-794. doi: 10.1017/S002221512100181X. Epub 2021 Jul 13. J Laryngol Otol. 2021. PMID: 34253269
Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAID.
Uzzan M, Nachury M, Nuzzo A, Amiot A, Caron B, Benezech A, Buisson A, Bouguen G, Le Berre C, Reenaers C, Le Cosquer G, Savoye G, Charkaoui M, Vidon M, Guillo L, Fumery M, Peyrin-Biroulet L, Kirchgesner J, Bouhnik Y; GETAID TOFA-PRO study group. Uzzan M, et al. J Crohns Colitis. 2024 Mar 1;18(3):424-430. doi: 10.1093/ecco-jcc/jjad169. J Crohns Colitis. 2024. PMID: 37796025 Free article.
Long-term effectiveness and acceptability of switching from intravenous to subcutaneous infliximab in patients with inflammatory bowel disease treated with intensified doses: The REMSWITCH-LT study.
Buisson A, Nachury M, Bazoge M, Yzet C, Wils P, Dodel M, Coban D, Pereira B, Fumery M. Buisson A, et al. Among authors: coban d. Aliment Pharmacol Ther. 2024 Feb;59(4):526-534. doi: 10.1111/apt.17822. Epub 2023 Nov 30. Aliment Pharmacol Ther. 2024. PMID: 38037279 Clinical Trial.
Confinement Assembly of Terpolymer-Based Janus Nanoparticles.
Azhdari S, Herrmann F, Coban D, Linders J, Gröschel AH. Azhdari S, et al. Among authors: coban d. Macromol Rapid Commun. 2022 Jul;43(14):e2100932. doi: 10.1002/marc.202100932. Epub 2022 Apr 21. Macromol Rapid Commun. 2022. PMID: 35377525
Role of adherent and invasive Escherichia coli in Crohn's disease: lessons from the postoperative recurrence model.
Buisson A, Sokol H, Hammoudi N, Nancey S, Treton X, Nachury M, Fumery M, Hébuterne X, Rodrigues M, Hugot JP, Boschetti G, Stefanescu C, Wils P, Seksik P, Le Bourhis L, Bezault M, Sauvanet P, Pereira B, Allez M, Barnich N; Remind study group. Buisson A, et al. Gut. 2023 Jan;72(1):39-48. doi: 10.1136/gutjnl-2021-325971. Epub 2022 Mar 31. Gut. 2023. PMID: 35361684 Clinical Trial.
96 results